Majority shareholders offering shares to institutional investors
Today, our majority shareholders LIVIA Corporate Development SE, HDI Vier CE GmbH and Edelweiß Holding GmbH notified us of their intention to place up to 18,000,000 shares, corresponding to approximately 17.7% of AlzChem Group AG 's share capital, with institutional investors via an accelerated bookbuilding. With this measure, our majority shareholders support the strategy of the Management Board of AlzChem Group AG which aims to increase the presence of the Company in the capital market, its free float and the liquidity of the shares.
About Alzchem
AlzChem Group AG is a vertically integrated manufacturer of various chemical products based on the NCN chain. These are products with typical nitrogen-carbon-nitrogen bonding that are used in a wide variety of different industries. The company has a leading position in select niche markets, including the markets for feed additives and food supplements. The strategic focus of growth and the main focus of its extensive research and development are on the business segment Specialty Chemicals. The company has around 1,500 employees at four sites in Germany and three other sites abroad.
Contact
Sabine Sieber
Head of Corporate Communications & Investor Relations
Alzchem Group AG
Dr.-Albert-Frank-Str. 32
83308 Trostberg
Germany